Congrats to @citytx_ on today’s @Nasdaq debut, $CTY 🔔
Founded by @JMaraganore and the team that pioneered RNAi at Alnylam, City is building the next generation of RNAi medicines.
We're proud to support City alongside our co-founder @rtnarch and ARCH Venture Partners.
We’re excited to announce the pricing of our upsized initial public offering at $18.00 per share, for gross proceeds of approximately $200.0 million. City will trade on Nasdaq under the ticker $CTY.
Read more: investors.citytx.com/news-re…
Rsquared retweeted
We’re excited to announce the pricing of our upsized initial public offering at $18.00 per share, for gross proceeds of approximately $200.0 million. City will trade on Nasdaq under the ticker $CTY.
Read more: investors.citytx.com/news-re…
The U.S. depends on its satellites more than ever, and they're increasingly exposed. @Fortastra_Corp builds spacecraft to protect them in orbit.
Congrats to the team on their $30M Series A led by First In!
Fortastra has raised $30 million to scale on-orbit security.
This capital will be used to expand our engineering team, accelerate development of our autonomy and rendezvous and proximity operations capabilities, and scale our manufacturing infrastructure. fortastra.com/newsroom/forta…
Rsquared retweeted
Replying to @mark43
@Mark43 has acquired @ForceMetrics, giving officers in the field the full picture before they arrive. Congrats to @AndrePlusData, Jason and the entire Forcemetrics team!
It's the second @Rsquaredvc public safety company acquired in the past year, after @Axon_enterprise acquired @Prepared_HQ.
Rsquared retweeted
Best partners and teammates I could ask for. Made the trip to Mallorca just to celebrate. Love y'all @rsquaredvc team 🥂
Rsquared retweeted
Today marks the European launch of PRIMA, the first and only treatment to be commercially available that restores functional central vision to patients with geographic atrophy caused by dry age-related macular degeneration, a leading cause of blindness.
The first European commercial implant of PRIMA is expected soon.
Rsquared retweeted
Definitely didn't expect the back-to-back. @DragosInc acquired @rsquaredvc portco @phosphorusinc earlier this month. Today Accenture's taking a majority stake in Dragos. OT security is not playing around. Congrats to both teams!
Accenture to Acquire Majority Stake in Dragos, All of runZero, NetRise in $4.1 Billion OT Cybersecurity Push securityweek.com/accenture-t…
The U.S. is treating quantum as a strategic national priority, and @Atom_Computing is one of the companies it's backing. $100M raised, plus @CommerceGov support, to scale fault-tolerant neutral-atom systems.
Proud to have backed this team from the early days. This is #nationalresilience.
Exclusive: U.S. government-backed quantum startup, Atom Computing, raises $100M axios.com/pro/all-deals/2026…
Rsquared retweeted
Alumni day was awesome, so many old faces, and new to meet. I thought I'd miss the computer history museum, but this space is spot on.
The future of American industry depends on building physical things faster. Aerospace, semiconductors, advanced manufacturing, without the decade-long timelines.
That's the bet @PrometheusInc is making, and why we backed them early. Congratulations to the team on today's launch!
CNBC's David Faber sits down for an exclusive interview with Prometheus co-founders and co-CEOs Jeff Bezos and Vik Bajaj.
Tune in to CNBC to watch live and follow this thread for updates. ⬇️ cnbc.com/2026/06/11/project-…
Counter-UAS has become the most crowded corner of defense tech — and one of the least proven. Plenty of systems claim to stop Group 1 threats. Very few actually do.
Today, @9Mothers emerged from stealth with EDDA: a tiny, affordable AI system small and cheap enough to put on every vehicle, every position, every asset — and operators on the ground say it's the only one that's stopped fast Group 1.
That distinction matters. Group 1 suicide drones are among the deadliest threats in modern warfare, and the fast-moving ones are exactly what fielded systems miss.
9 Mothers already has contracts, and has delivered. That's the bar for us — fielded capability, not promising demos.
We backed @rhs, Roman, and Bogdan early because they were the right team to solve exactly this. As a firm of former SOF operators, we've seen this threat up close — and we know the real thing when we see it.
Congratulations to the entire @9Mothers team, and to our partners @ycombinator, @pioneer_fund and @AllegisCapital. This is what national resilience looks like.
Proud moment for @rsquaredvc.
Today @DragosInc announced the acquisition of @phosphorusinc — a company we backed at seed in 2020 alongside founders Chris Rouland, Rebecca Rouland, and @earle.
Securing the connected device attack surface across critical infrastructure before the rest of the world caught up. This is exactly what we invest for at the intersection of national resilience and emerging technology.
Congrats to the entire Phosphorus team.
dragos.com/resource/press-re…
Rsquared retweeted
Full circle moment. Today @DragosInc announced the acquisition of @phosphorusinc — a company I was lucky enough to back at seed as my first investment at @rsquaredvc.
When I transitioned out of the Army, Chris Rouland gave me my first real shot in this industry at @EndgameInc. I got to see firsthand what Chris and @earle built there. That chance changed the trajectory of my career.
So when they founded Phosphorus in 2018, I was paying attention. Backing them was one of the easiest calls I’ve ever made. You back people you’ve seen build before.
Congrats to Chris, Earle, and the entire Phosphorus team for securing the connected device attack surface across critical infrastructure before the rest of the world caught up.
dragos.com/resource/press-re…
National Resilience isn't just a thesis — it's outcomes like this.
Proud to share that Vaccine Company has entered into a definitive agreement to be acquired by Eli Lilly and Company for up to $1.55 billion.
Congratulations to the VaxCo team and everyone who played a part in this story. More to come.
prnewswire.com/news-releases…
“All gave some. Some gave all.”
For our team — most of whom served — those words come with names and faces.
We invest in national resilience because the country they died for is worth continued service and defense. We carry that mission forward in their honor.
To the fallen, and to the families who carry on: we remember.
Rsquared retweeted
Max Hodak’s Science Corp. is preparing to place its first sensor in a human brain techcrunch.com/2026/04/14/ma…
Rsquared retweeted
Manufacturing is still pre-AWS.
Locked behind capex, tooling, and gatekeepers.
We need the Linux moment:
open, messy, community-driven hardware products.
High mix × high volume.
Anyone can build, not just those who can afford factories.
We need manufacturing abstraction the way Amazon Web Services hid data centers.
No tooling. General-purpose factories. Same hardware, infinite products.
Until then, incumbents hoard the data
and worse… there isn’t much of it.
Too few players.
Too few products.
Way below what an exciting future could look like.
Replying to @EdwardMehr
90% of training data is domain-specfic and privately held by individual companies. So there'll be marketplaces for use case specific data. As for new data generated, that'll be subject to licensing. Those who pay for robots will want to own what robots generate.
Rsquared retweeted
Science has won the iF Design Award 2026 for Product Design in the Medical/Healthcare category for the Axon Terminal, part of the Science Ecosystem. Science partnered with the design firm @Card_79 on the project.
The independent jury describes Axon Terminal as “a portable neural signal simulator, like an ‘MP3 player for neural data.’ It enables researchers to load, browse, and play pre-recorded neural signals, offering a precise yet approachable interface for neuroscience experimentation. Its unique form feels familiar like consumer tech, yet purpose-built for scientific rigor. By uniting ergonomic hardware, clear feedback, and durable construction, the Axon Terminal bridges advanced neural technology with human-centered usability—delivering clarity, comfort, and confidence in every interaction.”
Read more here: science.xyz/news/if-design-a…
What shapes an investment thesis? For our Managing Partner @jeff_eggers, it starts with 20 years as a Navy SEAL, deployments across four continents, and time advising at the National Security Council where the weight of policy decisions meets real-world consequence.
That background sharpens how you evaluate risk, leadership, and long-term impact. It’s exactly the lens we bring to investing at Rsquared .
Jeff sat down with @RennyMcPherson and Josh Bates on The Green Door podcast to share that thinking. Worth a listen. 🎙️
podcasts.apple.com/us/podcas…




















